C-patch Grande
NDC Package 70236-101-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

C-patch Grande is adults and children over 12 years:- Clean affected skin- Remove film from patch- Carefully apply the patch to the affected region and press skin firmly- Patch can remain on the skin for up to 8 hours- May repeat as necessary up to a maximum of 3 times per day- For tick and bee stings, remove tick or stinger before applying patchChildren 12 years and younger: ask a health professional. Marketed by Neobiotech Global Corporation, this product is identified by NDC 70236-101 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
70236-101-02
Package Description
6 PATCH in 1 POUCH / 28 g in 1 PATCH (70236-101-01)
Product Code
70236-101
11-Digit Billing Format
70236010102
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
C-patch Grande
Dosage Form
-
Usage Information
Adults and children over 12 years:- Clean affected skin- Remove film from patch- Carefully apply the patch to the affected region and press skin firmly- Patch can remain on the skin for up to 8 hours- May repeat as necessary up to a maximum of 3 times per day- For tick and bee stings, remove tick or stinger before applying patchChildren 12 years and younger: ask a health professional

Regulatory & Marketing

Labeler Name
Neobiotech Global Corporation
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
01-13-2018
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70236-101-02 identifies a specific commercial package of 6 patch in 1 pouch / 28 g in 1 patch (70236-101-01) of C-patch Grande, labeled by Neobiotech Global Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Neobiotech Global Corporation on January 13, 2018. The current certification is valid through December 31, 2019.

How is this Neobiotech Global Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70236010102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70236-101-02
11-Digit CMS (5-4-2)
70236-0101-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.